These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 7853752

  • 1. Reduction of albuminuria by a calcium antagonist, manidipine, in rats with passive Heymann nephritis.
    Arai T, Kobayashi S, Nakajima T, Hishida A.
    Nihon Jinzo Gakkai Shi; 1994 Nov; 36(11):1216-20. PubMed ID: 7853752
    [Abstract] [Full Text] [Related]

  • 2. Effects on urinary albumin excretion and renal function changes by delapril and manidipine in normotensive type 2 diabetic patients with microalbuminuria.
    Deerochanawong C, Kornthong P, Phongwiratchai S, Serirat S.
    J Med Assoc Thai; 2001 Feb; 84(2):234-41. PubMed ID: 11336083
    [Abstract] [Full Text] [Related]

  • 3. Manidipine treatment in patients with albuminuria not sufficiently reduced with renin-angiotensin system blockers.
    Galceran J, Plana J, Felip A, Pou G, Vila J, Sobrino J.
    Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):751-7. PubMed ID: 20528630
    [Abstract] [Full Text] [Related]

  • 4. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
    Rodicio JL.
    Blood Press Suppl; 1996 Jun; 5():10-5. PubMed ID: 8973787
    [Abstract] [Full Text] [Related]

  • 5. Effects of a calcium antagonist, manidipine, on progressive renal injury associated with mild hypertension in remnant kidneys.
    Kobayashi S, Hishida A.
    J Lab Clin Med; 1995 May; 125(5):572-80. PubMed ID: 7738423
    [Abstract] [Full Text] [Related]

  • 6. Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.
    Ishimitsu T, Kameda T, Akashiba A, Takahashi T, Ohta S, Yoshii M, Minami J, Ono H, Numabe A, Matsuoka H.
    Hypertens Res; 2007 Jul; 30(7):621-6. PubMed ID: 17785930
    [Abstract] [Full Text] [Related]

  • 7. Manidipine in hypertensive patients with metabolic syndrome: the MARIMBA study.
    Martínez Martín FJ.
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):863-9. PubMed ID: 19589122
    [Abstract] [Full Text] [Related]

  • 8. Manidipine attenuates a progressive renal injury in remnant kidneys of rats.
    Kobayashi S, Hishida A.
    Blood Press Suppl; 1992 Jul; 3():80-4. PubMed ID: 1343296
    [Abstract] [Full Text] [Related]

  • 9. Clinical evaluation of the efficacy and safety of manidipine in hypertensive patients with renal disorders.
    Mizuno K, Haga H, Takahashi M, Watanabe Y, Fukuchi S.
    Blood Press Suppl; 1992 Jul; 3():119-23. PubMed ID: 1343279
    [Abstract] [Full Text] [Related]

  • 10. Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study.
    Martinez-Martin FJ, Saiz-Satjes M.
    Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1347-55. PubMed ID: 19018688
    [Abstract] [Full Text] [Related]

  • 11. [Calcium channel-blockers for managing metabolic syndrome-associated hypertension. Trials with manidipine].
    Martínez Martín FJ.
    Nefrologia; 2007 Nov; 27 Suppl 6():26-35. PubMed ID: 18225601
    [No Abstract] [Full Text] [Related]

  • 12. Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria.
    Abe M, Okada K, Maruyama N, Matsumoto S, Maruyama T, Fujita T, Matsumoto K, Soma M.
    Hypertens Res; 2011 Feb; 34(2):268-73. PubMed ID: 21124330
    [Abstract] [Full Text] [Related]

  • 13. Renal vascular responses in spontaneously hypertensive rats chronically treated with manidipine.
    Muratani H, Takishita S, Kawazoe N, Tozawa M, Fukiyama K.
    Blood Press Suppl; 1992 Feb; 3():60-7. PubMed ID: 1343293
    [Abstract] [Full Text] [Related]

  • 14. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR, Shand BI, Smith AH, Robson RA, Lynn KL.
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [Abstract] [Full Text] [Related]

  • 15. Vascular and metabolic properties of manidipine.
    Buset Ríos N, Rodríguez Esparragón F, Fernández-Andrade Rodríguez C, Rodríguez Pérez JC.
    Nefrologia; 2011 Oct; 31(3):268-74. PubMed ID: 21407275
    [Abstract] [Full Text] [Related]

  • 16. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C, Corna D, Bruzzi I, Foglieni C, Bertani T, Remuzzi G, Benigni A.
    Exp Nephrol; 1996 Oct; 4(4):213-21. PubMed ID: 8983642
    [Abstract] [Full Text] [Related]

  • 17. Effects of a new calcium antagonist, manidipine, on the renal hemodynamics and the vasoactive humoral factors in patients with diabetes mellitus.
    Hirakata H, Iino K, Ishida I, Kashiwagi M, Yoshinari M, Okuda S, Fujita S, Fujishima M.
    Blood Press Suppl; 1992 Oct; 3():124-9. PubMed ID: 1343281
    [Abstract] [Full Text] [Related]

  • 18. Preventive effect of manidipine on severe hypertension and proteinuria induced by the inhibition of endothelial-derived relaxation factor formation in stroke-prone spontaneously hypertensive rats.
    Nara Y, Ikeda K, Yamori Y.
    Blood Press Suppl; 1992 Oct; 3():85-6. PubMed ID: 1343297
    [Abstract] [Full Text] [Related]

  • 19. Urinary albumin excretion during angiotensin II receptor blockade: comparison of combination treatment with a diuretic or a calcium-channel blocker.
    Matsui Y, Eguchi K, Ishikawa J, Shimada K, Kario K.
    Am J Hypertens; 2011 Apr; 24(4):466-73. PubMed ID: 21164498
    [Abstract] [Full Text] [Related]

  • 20. Effects of manidipine on blood pressure and renal function in salt-loaded, spontaneously hypertensive rats.
    Ikenaga H, Suzuki H, Saruta T.
    Blood Press Suppl; 1992 Apr; 3():75-9. PubMed ID: 1343295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.